-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: BIOtechNOW Editor
The UK at BIO
There are more than 400 delegates from the UK attending the 2013 BIO International Convention. These include delegates from four innovative life science companies – Abcodia, Critical Pharmaceuticals, Nanomerics, and PsiOxus Therapeutics – who won the recent UK Trade and Investment (UKTI) Innovation Competition and will showcase their technologies to an international audience in Chicago. The UK presence at the convention will be centred on the UK pavilion (stand 4441) hosted by the BioIndustry Association (BIA) Read More >
Evidence, Coverage, & Incentives: A PMC/BIO Solutions Summit Conference
Personalized medicine is changing the way medicine is practiced, and how drugs and biologics are developed. Systemic changes are needed to reflect this and support product development, but current economic, regulatory, and practice disincentives are impacting and slowing development. For example, medical advances often take years to be recognized in clinical care guidelines and cost containment policies often prevent new diagnostics from being priced at a level that supports innovation. The Personalized Medicine Coalition (PMC) and Read More >
The BioGENEius Challenge is a Keystone Event at the BIO International Convention
Part Two: A Look Forward Read part one of Robert’s story Enabling future biotechnology leaders The primary success of the BioGENEius Challenge is bringing biotechnology into the schools of our communities, engaging tens of thousands of students, teachers and parents in the scientific process. Equal opportunity to engage in the scientific process has been established through open access to tools and educational materials made available through this program. This is a fundamental principle of the Read More >
The BioGENEius Challenge is a Keystone Event at the BIO International Convention
Part One: A Look Back Read part two of Robert’s story The gathering of leaders in biotechnology has been an annual event for 20 years, but did you know that some of the best and brightest in attendance are still in high school? Every year, the International BioGENEius Challenge invites the top biotechnology science competition winners from high schools across the United States, Canada and Western Australia to showcase their work and compete in what Read More >
Diversity Critical to Building Rich Bioscience Centers
Whether producing natural gas from coal or creating lifesaving medicines, unique experiences are what often lead to great discoveries. The more diverse the backgrounds and interests of those working in life sciences, the richer our discoveries are bound to be. Considering the diversity of our country, it’s not surprising that the U.S. is the most prolific country in the world in terms of life science or bioscience discoveries. And many of these are happening right Read More >
